Immunoblotting was performed as previously described [32 (link)]. The following antibodies were used in this study: anti-MCPyV-LT (CM2B4; Santa Cruz Biotechnology, Dallas, TX, USA), anti-MCPyV-TA (2T2 hybridoma supernatant; [34 (link)]), anti-AURKA (1G4; Cell Signaling, Danvers, MA, USA), anti-β-tubulin (TUB 2.1; Sigma-Aldrich, Taufkirchen, Germany) and anti-vinculin (V9131; Sigma Aldrich).
Free full text: Click here